altair_8k-050708.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
____________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported):  May 7, 2008
 
Altair Nanotechnologies Inc.
(Exact Name of Registrant as Specified in its Charter)
 
Canada
1-12497
 33-1084375
(State or other jurisdiction of
incorporation or organization)
(Commission 
File Number)
(IRS Employer
Identification No.)
 
204 Edison Way
Reno, NV
 89502
(Address of Principal Executive Offices)
(Zip Code)
 
Registrant's Telephone Number, Including Area Code:
(801) 858-3750
N/A
(Former name, former address, and formal fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 [ ]   
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 [ ]   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 [ ]    
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 [ ]   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
   
 
  
Item 2.02  Results of Operations and Financial Condition.

On May 7, 2008, Altair Nanotechnologies Inc. (the "Company") issued a press release entitled “Altair Nantechnologies Reports First Quarter 2008 Financial Results.” The full text of the press release is provided herewith as Exhibit 99.1.

The information in Item 2.02 of this Report  (including  exhibit 99.1) shall not be deemed to be "filed" for  purposes of Section 18 of the  Securities  Exchange Act of 1934,  as amended  (the  "Exchange  Act"),  or  otherwise  subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended,  or the Exchange Act, except as expressly set forth by specific  reference in such a filing.

Item 9.01  Financial Statements and Exhibits.

(d)           Exhibits.

99.1 Press Release issued by the Company dated May 7, 2008

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
Dated:  May 7, 2008     
Altair Nanotechnologies Inc.
 
 
By /s/ John Fallini                                             
John Fallini, Chief Financial Officer